- Home
- NTRSO vs OSRHW Comparison
NTRSO vs OSRHW Comparison
Compare NTRSO & OSRHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRSO
- OSRHW
- Stock Information
- Founded
- NTRSO N/A
- OSRHW N/A
- Country
- NTRSO United States
- OSRHW United States
- Employees
- NTRSO 23300
- OSRHW 21
- Industry
- NTRSO Major Banks
- OSRHW
- Sector
- NTRSO Finance
- OSRHW
- Exchange
- NTRSO Nasdaq
- OSRHW Nasdaq
- Market Cap
- NTRSO N/A
- OSRHW N/A
- IPO Year
- NTRSO N/A
- OSRHW 2023
- Fundamental
- Price
- NTRSO $20.11
- OSRHW $0.05
- Analyst Decision
- NTRSO
- OSRHW
- Analyst Count
- NTRSO 0
- OSRHW 0
- Target Price
- NTRSO N/A
- OSRHW N/A
- AVG Volume (30 Days)
- NTRSO N/A
- OSRHW N/A
- Earning Date
- NTRSO N/A
- OSRHW N/A
- Dividend Yield
- NTRSO N/A
- OSRHW N/A
- EPS Growth
- NTRSO N/A
- OSRHW N/A
- EPS
- NTRSO N/A
- OSRHW N/A
- Revenue
- NTRSO N/A
- OSRHW N/A
- Revenue This Year
- NTRSO N/A
- OSRHW N/A
- Revenue Next Year
- NTRSO N/A
- OSRHW N/A
- P/E Ratio
- NTRSO N/A
- OSRHW N/A
- Revenue Growth
- NTRSO N/A
- OSRHW N/A
- 52 Week Low
- NTRSO N/A
- OSRHW N/A
- 52 Week High
- NTRSO N/A
- OSRHW N/A
- Technical
- Relative Strength Index (RSI)
- NTRSO 52.92
- OSRHW N/A
- Support Level
- NTRSO $20.06
- OSRHW N/A
- Resistance Level
- NTRSO $20.48
- OSRHW N/A
- Average True Range (ATR)
- NTRSO 0.20
- OSRHW 0.00
- MACD
- NTRSO -0.02
- OSRHW 0.00
- Stochastic Oscillator
- NTRSO 31.48
- OSRHW 0.00
About NTRSO Northern Trust Corporation
Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of December 2024, Northern Trust had assets under custody or administration of $16.8 trillion and assets under management of $1.6 trillion.
About OSRHW OSR Holdings Inc. Warrant
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.